|[November 01, 2013]
Research and Markets: Arimenda (Alzheimer's Disease) - Forecast and Market Analysis to 2022
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/dwqdmd/arimenda)
has announced the addition of the "Arimenda
(Alzheimer's Disease) - Forecast and Market Analysis to 2022"
report to their offering.
There are no long-term effective therapies for Alzheimer's Disease (AD),
so this remains at the top of the list for unmet needs. While physicians
agree that symptomatic therapies are relatively safe and effective,
these therapies are still lacking because of they cannot maintain their
effects and lack mechanisms that alter the course of the disease.
Arimenda is a once-daily fixed-dose combination (FDC) of an ER form of
memantine, an NMDA receptor antagonist, and donepezil, an AChEI. It is
developed to overcome low compliance in patients who are taking the two
drugs separately. It provides full-strength dosing fom the start of
treatment to enable a more rapid and convenient attainment of
therapeutic plasma levels of the two compounds.
- Overview of AD, including epidemiology, etiology, symptoms, diagnosis,
pathology and treatment guidelines as well as an overview on the
- Detailed information on Arimenda including product description, safety
and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Arimenda for the top seven countries from 2012 to
- Sales information covered for the US, France, Germany, Italy, Spain,
the UK and Japan.
Reasons to Buy
- Understand and capitalize by identifying products that are most likely
to ensure a robust return
- Stay ahead of the competition by understanding the changing
competitive landscape for AD
- Effectively plan your M&A and partnership strategies by identifying
drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth
analysis of Arimenda performance
Key Topics Covered
1 List of Tables and Figures
3 Disease Overview
4 Disease Management
5 Competitive Assessment
6 Opportunity and Unmet Need
7 Pipeline Assessment
For more information visit http://www.researchandmarkets.com/research/dwqdmd/arimenda
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]